Boston Scientific Puts Snake Venom Unit Up for Sale

(Bloomberg) -- Boston Scientific Corp. is exploring a sale of its specialty pharmaceutical business focused on treatments for snake venom, which could fetch close to $1 billion, according to people...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.